Cellular responses to low nutrient conditions via activation of lysophosphatidic acid (LPA) receptor signaling in gastric cancer cells

Q1 Biochemistry, Genetics and Molecular Biology Advances in biological regulation Pub Date : 2024-11-30 DOI:10.1016/j.jbior.2024.101068
Narumi Yashiro, Miwa Takai, Mao Yamamoto, Yuka Kusumoto, Shion Nagano, Anri Taniguchi, Moemi Tamura, Toshifumi Tsujiuchi
{"title":"Cellular responses to low nutrient conditions via activation of lysophosphatidic acid (LPA) receptor signaling in gastric cancer cells","authors":"Narumi Yashiro,&nbsp;Miwa Takai,&nbsp;Mao Yamamoto,&nbsp;Yuka Kusumoto,&nbsp;Shion Nagano,&nbsp;Anri Taniguchi,&nbsp;Moemi Tamura,&nbsp;Toshifumi Tsujiuchi","doi":"10.1016/j.jbior.2024.101068","DOIUrl":null,"url":null,"abstract":"<div><div>In the center of the solid tumor, abnormal vascular architecture impedes sufficient blood supply, leading to continuous hypoxia and nutrient deprivation for the tumor cells. Lysophosphatidic acid (LPA) receptor signaling is known to drive a range of malignant behaviors in cancer cells. This study aimed to explore the impact of LPA receptors on cellular functions in gastric cancer AGS cells cultured under low nutrient conditions. When AGS cells were cultured in media containing low glucose (2000 mg/L), low glutamine (1 mM), or low amino acids (50 % content), LPA receptor expression levels were significantly altered. The growth activity of AGS cells cultured in low glucose- and low amino acid-containing media was suppressed by LPA. Conversely, LPA increased the growth activity of AGS cells cultured in low glutamine-containing media. AGS cell motility increased under low glucose and low glutamine conditions, while low amino acid conditions decreased cell motility. Additionally, the viability of AGS cells in response to cisplatin (CDDP) was enhanced under low glucose, low glutamine, and low amino acid conditions. The motility and viability of AGS cells in response to CDDP were significantly increased by AM966 (LPA<sub>1</sub> antagonist), GRI-977143 (LPA<sub>2</sub> agonist) and (2S)-OMPT (LPA<sub>3</sub> agonist). These results suggest that LPA receptor signaling is significantly implicated in regulating malignant properties in AGS cells under low nutrient conditions.</div></div>","PeriodicalId":7214,"journal":{"name":"Advances in biological regulation","volume":"96 ","pages":"Article 101068"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in biological regulation","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212492624000563","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

In the center of the solid tumor, abnormal vascular architecture impedes sufficient blood supply, leading to continuous hypoxia and nutrient deprivation for the tumor cells. Lysophosphatidic acid (LPA) receptor signaling is known to drive a range of malignant behaviors in cancer cells. This study aimed to explore the impact of LPA receptors on cellular functions in gastric cancer AGS cells cultured under low nutrient conditions. When AGS cells were cultured in media containing low glucose (2000 mg/L), low glutamine (1 mM), or low amino acids (50 % content), LPA receptor expression levels were significantly altered. The growth activity of AGS cells cultured in low glucose- and low amino acid-containing media was suppressed by LPA. Conversely, LPA increased the growth activity of AGS cells cultured in low glutamine-containing media. AGS cell motility increased under low glucose and low glutamine conditions, while low amino acid conditions decreased cell motility. Additionally, the viability of AGS cells in response to cisplatin (CDDP) was enhanced under low glucose, low glutamine, and low amino acid conditions. The motility and viability of AGS cells in response to CDDP were significantly increased by AM966 (LPA1 antagonist), GRI-977143 (LPA2 agonist) and (2S)-OMPT (LPA3 agonist). These results suggest that LPA receptor signaling is significantly implicated in regulating malignant properties in AGS cells under low nutrient conditions.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
胃癌细胞通过激活溶血磷脂酸(LPA)受体信号对低营养条件的细胞反应
在实体瘤中心,异常的血管结构阻碍了充足的血液供应,导致肿瘤细胞持续缺氧和营养剥夺。已知溶血磷脂酸(LPA)受体信号传导可驱动癌细胞的一系列恶性行为。本研究旨在探讨低营养条件下LPA受体对胃癌AGS细胞功能的影响。当AGS细胞在低葡萄糖(2000 mg/L)、低谷氨酰胺(1 mM)或低氨基酸(50%含量)培养基中培养时,LPA受体表达水平显著改变。低糖低氨基酸培养基培养的AGS细胞生长活性受到LPA的抑制。相反,LPA能提高低谷氨酰胺培养基中AGS细胞的生长活性。低葡萄糖和低谷氨酰胺条件下AGS细胞运动增强,低氨基酸条件下细胞运动减弱。此外,在低葡萄糖、低谷氨酰胺和低氨基酸条件下,AGS细胞对顺铂(CDDP)的反应活性增强。AM966 (LPA1拮抗剂)、GRI-977143 (LPA2激动剂)和(2S)-OMPT (LPA3激动剂)显著提高了AGS细胞对CDDP反应的运动性和活力。这些结果表明,在低营养条件下,LPA受体信号显著参与调节AGS细胞的恶性特性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Advances in biological regulation
Advances in biological regulation Biochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
8.90
自引率
0.00%
发文量
41
审稿时长
17 days
期刊最新文献
Foreword. Insights into phosphatidic acid phosphatase and its potential role as a therapeutic target. TP53 gene status can promote sensitivity and resistance to chemotherapeutic drugs and small molecule signal transduction inhibitors. Molecular basis of JAK kinase regulation guiding therapeutic approaches: Evaluating the JAK3 pseudokinase domain as a drug target. Tissue specific roles of fatty acid oxidation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1